Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 48.19 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.91 | -1.85% | 48.19 | 50.09 | 48.1839 | 49.35 | 49.10 | 00:00:04 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 48.19 | 62.37 | 14.18 | 22.74% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,448 | 415,210 | $ 48.92 | $ 20,310,234 | 494,784 | 30.38 - 63.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:08:26 | formt | 6,294 | $ 48.19 | USD |
REGENXBIO Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 1.78B | 36.87M | $ 99.94M | 2.84 | - | 36.36M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
REGENXBIO News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.90 | 50.09 | 42.32 | 46.06 | 579,392 | 5.29 | 12.33% |
| 1 Month | 41.39 | 50.09 | 37.76 | 42.54 | 477,071 | 6.80 | 16.43% |
| 3 Months | 38.47 | 50.09 | 34.02 | 40.81 | 491,465 | 9.72 | 25.27% |
| 6 Months | 46.96 | 54.9071 | 30.38 | 39.65 | 527,870 | 1.23 | 2.62% |
| 1 Year | 43.89 | 63.21 | 30.38 | 44.84 | 531,773 | 4.30 | 9.8% |
| 3 Years | 19.30 | 85.10 | 16.30 | 44.24 | 448,083 | 28.89 | 149.69% |
| 5 Years | 30.26 | 85.10 | 7.0701 | 40.50 | 361,794 | 17.93 | 59.25% |
REGENXBIO Description
| Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |
